Last reviewed · How we verify
Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect
The primary purpose of this substudy is to determine if collagen-targeted PET using the type 1 collagen-targeted PET probe, Gallium-68 (68Ga)-labeled collagen binding probe 8 (CBP8) can inform as to drug effect of EGCG and assist in dose selection.
Details
| Lead sponsor | Hal Chapman |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 12 |
| Start date | Wed Feb 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Jan 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Idiopathic Pulmonary Fibrosis
Interventions
- EGCG 300 mg
- Placebo for EGCG 300 mg
- EGCG 600 mg
- Placebo for EGCG 600 mg
Countries
United States